INV 003
Alternative Names: INV-003Latest Information Update: 20 Oct 2023
At a glance
- Originator Innovac Therapeutics
- Class RNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Infections
Most Recent Events
- 11 Sep 2023 Early research in Infections (Prevention) in USA (Parenteral) prior to September 2023 (Innovac Therapeutics pipeline, September 2023)
- 11 Sep 2023 Early research in Infections in USA (Parenteral) prior to September 2023 (Innovac Therapeutics pipeline, September 2023)